India’s Shift to High-Value, Innovation-Led Pharma: Spotlight on GLP-1
India’s GLP-1 market opened up almost overnight. Semaglutide came off patent in March 2026, and multiple Indian manufacturers launched generics […]
VENUS-REMEDIES-LTD
Cipla acquires anti-infective product Elores from Venus Remedies
Pharma major Cipla has acquired a novel and patented anti-infective product, Elores, from Venus Remedies Ltd (VRL) for the Indian […]
